MAPT and Alzheimer disease: However, there are decreased amounts of tau in plasma compared to CSF (Barten et al., 2017; Mattsson et al., 2017b), but increases have been found in plasma of AD patients when compared to MCI patients and healthy controls (Figure 3; Mattsson et al., 2016; Pase et al., 2019).